| 1 |
Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity
Wen Wee Ma, Muhammad Wasif Saif, Bassel F. El‐Rayes et al. · Cancer
Open access |
13 Sep 2016 |
126 |
| 2 |
Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease
Joel A. Saydoff, Lian Sheng Liu, Rolando A.G. Garcia et al. · Brain Research
|
29 Oct 2003 |
54 |
| 3 |
Uridine Prodrug Improves Memory in Tg2576 and TAPP Mice and Reduces Pathological Factors associated with Alzheimer's Disease in Related Models
Joel A. Saydoff, Ana Olariu, Jin G. Sheng et al. · Journal of Alzheimer s Disease
|
5 Aug 2013 |
35 |
| 4 |
Use of uridine triacetate for the management of fluorouracil overdose
Margaret McEvilly, Carl Popelas, Bob Tremmel · American Journal of Health-System Pharmacy
|
19 Sep 2011 |
33 |
| 5 |
Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease
Joel A. Saydoff, Rolando A.G. Garcia, Susan E. Browne et al. · Neurobiology of Disease
Open access |
30 Sep 2006 |
29 |
| 6 |
Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status
Bernice Lo, Austin D.-E. Swafford, Kimberly Shafer-Weaver et al. · Journal of Translational Medicine
Open access |
28 Nov 2011 |
25 |
| 7 |
5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice
Muhammad Wasif Saif, Reid von Borstel · Cancer Chemotherapy and Pharmacology
|
26 Sep 2005 |
19 |
| 8 |
Neuroprotective Effects of Oral Administration of Triacetyluridine Against MPTP Neurotoxicity
Péter Klivènyi, Gabrielle Gardian, Noel Ylagan Calingasan et al. · NeuroMolecular Medicine
|
2004 |
15 |
| 9 |
Epitope Specificities of the Group Y and W-135 Polysaccharides ofNeisseria meningitidis
Samuel Moore, Catherine Uitz, Chang‐Chun Ling et al. · Clinical and Vaccine Immunology
Open access |
6 Sep 2007 |
13 |
| 10 |
Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice
Juha Grönholm, Philippe P. Pagni, Minh Nguyet Pham et al. · Diabetologia
Open access |
28 Apr 2017 |
10 |
| 11 |
Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine
Rolando A.G. Garcia, Liansheng Liu, Zhongyi Hu et al. · Brain Research
|
Dec 2005 |
8 |
| 12 |
Prompt treatment with uridine triacetate improves survival and reduces toxicity due to fluorouracil and capecitabine overdose or dihydropyrimidine dehydrogenase deficiency
Rolando A.G. Garcia, Joel A. Saydoff, Michael K. Bamat et al. · Toxicology and Applied Pharmacology
|
14 Jun 2018 |
5 |
| 13 |
Clinical Experience with Uridine Triacetate for 5-Fluorouracil Overexposure: an Update
Michael K. Bamat, Robert Tremmel, Joan Helton et al. · Annals of Oncology
Open access |
Jun 2013 |
4 |
| 14 |
Mobility and Speed in a Workover/ Completion Rig for the Arctic
G. B. Gardner, P. P. Snisarenko
Conference paper |
28 Feb 1989 |
4 |
| 15 |
[P‐188]: PN401 decreases neurodegeneration in models of Alzheimer's, Huntington's and Parkinson's disease, neuroinflammation, excitotoxicity and has antiepileptic activity
Joel A. Saydoff, Jin G. Sheng, Zhongyi Hu et al. · Alzheimer s & Dementia
Open access |
Jul 2005 |
1 |
| 16 |
On the CCG footprint.
Tim Riley · PubMed
|
9 Feb 2012 |
0 |
| 17 |
Novel Point-Of-Use FXa Assay For Monitoring Anticoagulant Therapy By Oral Factor Xa Inhibitors and Heparin
Nina I. Lukinova, Mano Venkatesan, Jill White · Blood
|
15 Nov 2013 |
0 |
| 18 |
P4‐307: PN401 treatment improves memory in Tg2576 and TAPP models of Alzheimer's disease
Joel A. Saydoff, Ana Olariu, Zhongyi Hu et al. · Alzheimer s & Dementia
|
Jul 2008 |
0 |